Mar 16 2011
LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries, that will allow the organizations to provide superior testing services to a broader base of clients in the reproductive health industry.
This partnership will make Ambry Genetics the preferred provider of genetic carrier screening for LABS, Inc., giving LABS' testing clients access to AmbryScreen™, a genetic screening test used to identify carriers of some of the most severe and common childhood diseases affecting pan-ethnic populations.
"This partnership brings two premier laboratories together to offer new donor and patient screening options combined with an elite level of service that is unparalleled in the reproductive health industry," said Elizabeth Hearty, Chief Executive Officer of LABS, Inc. "Ambry also brings to the table strong innovation and cutting-edge technologies within the genetic diagnostic market and that will effectively serve our clients."
Ambry is a specialized laboratory focused solely on genetic testing and diagnostic services. The Company operates in a highly consultative manner with hands-on customer service and individualized attention. LABS, Inc. has been serving the transplant community for nearly 30 years in the areas of infectious disease, immunogenetics and microbiology. LABS, Inc. brings unparalleled consultative and regulatory expertise to its customers.
"We are excited about partnering with LABS, Inc. to give more people access to this critical genetic test," said Steven Keiles, Vice President of Diagnostic Services of Ambry Genetics. "LABS, Inc.'s reputation for excellence in the reproductive health field made them a perfect partner to expand our offerings."
Healthy lifestyle choices can offset genetic risk for brain diseases